- Home
- CEAD vs PRTG Comparison
CEAD vs PRTG Comparison
Compare CEAD & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- PRTG
- Stock Information
- Founded
- CEAD 2009
- PRTG 1973
- Country
- CEAD United States
- PRTG British Virgin Islands
- Employees
- CEAD N/A
- PRTG N/A
- Industry
- CEAD Industrial Machinery/Components
- PRTG Oil & Gas Production
- Sector
- CEAD Industrials
- PRTG Energy
- Exchange
- CEAD Nasdaq
- PRTG Nasdaq
- Market Cap
- CEAD 5.6M
- PRTG 4.7M
- IPO Year
- CEAD N/A
- PRTG N/A
- Fundamental
- Price
- CEAD $6.00
- PRTG $4.69
- Analyst Decision
- CEAD
- PRTG Hold
- Analyst Count
- CEAD 0
- PRTG 1
- Target Price
- CEAD N/A
- PRTG N/A
- AVG Volume (30 Days)
- CEAD 10.5K
- PRTG 40.3K
- Earning Date
- CEAD 11-14-2024
- PRTG 12-03-2024
- Dividend Yield
- CEAD N/A
- PRTG N/A
- EPS Growth
- CEAD N/A
- PRTG N/A
- EPS
- CEAD N/A
- PRTG N/A
- Revenue
- CEAD $2,637,116.00
- PRTG N/A
- Revenue This Year
- CEAD N/A
- PRTG N/A
- Revenue Next Year
- CEAD N/A
- PRTG N/A
- P/E Ratio
- CEAD N/A
- PRTG N/A
- Revenue Growth
- CEAD N/A
- PRTG N/A
- 52 Week Low
- CEAD $5.22
- PRTG $2.10
- 52 Week High
- CEAD $11.04
- PRTG $40.80
- Technical
- Relative Strength Index (RSI)
- CEAD 30.79
- PRTG 46.17
- Support Level
- CEAD $5.60
- PRTG $3.81
- Resistance Level
- CEAD $6.61
- PRTG $4.78
- Average True Range (ATR)
- CEAD 0.31
- PRTG 0.56
- MACD
- CEAD -0.09
- PRTG 0.04
- Stochastic Oscillator
- CEAD 26.44
- PRTG 56.33
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.